0001209191-18-005377.txt : 20180125 0001209191-18-005377.hdr.sgml : 20180125 20180125162646 ACCESSION NUMBER: 0001209191-18-005377 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180123 FILED AS OF DATE: 20180125 DATE AS OF CHANGE: 20180125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Danziger Asaf CENTRAL INDEX KEY: 0001654435 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 18548544 MAIL ADDRESS: STREET 1: 5 NACHUM CHAT ST. CITY: TIRAT HACARMEL STATE: L3 ZIP: 5112302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Novocure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER CITY: ST. HELIER STATE: Y9 ZIP: JE2 4YE BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER CITY: ST. HELIER STATE: Y9 ZIP: JE2 4YE 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-23 0 0001645113 Novocure Ltd NVCR 0001654435 Danziger Asaf C/O NOVOCURE INC. 20 VALLEY STREAM PARKWAY, SUITE 300 MALVERN PA 19355 1 1 0 0 Chief Executive Officer Ordinary Shares 2018-01-23 4 S 0 10248 22.033 D 387820 D Ordinary Shares 2018-01-24 4 S 0 10600 22.1705 D 377220 D On January 23, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 10,248 shares in multiple trades at prices ranging from $22.00 to $22.15. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. On January 24, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 10,600 shares in multiple trades at prices ranging from $22.00 to $22.45. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. By: /s/ Todd Longsworth, Attorney in fact for Asaf Danziger 2018-01-25